Section Menu
10. J. Kim, “Biological implications of benzoquinones” (Book Chapter) in the book “Quinone: Occurrence, Medicinal Uses and Physiological Importance”, Nova Science Publishers, Inc., 2013, ISBN 978-1-62618-323-0.
9. A. R. Vaughn; C. B. Redman; S. M. Kang; J. Kim "Biological Implications of 2-Chlorocyclohexa-2,5-diene-1,4-dione toward Ribonuclease A", Advances in Bioscience and Biotechnology, 2013, 4, 22-28.
8.  J. Kim; A. R. Vaughn; C. Cho; T.V. Albu; E. A. Carver "Modifications of ribonuclease A induced by p-benzoquinone", Bioorganic Chemistry, 2012, 40, 92.
 7.  J. Kim; Y, Zhang; C, Ran; L. M. Sayre "Inactivation of bovine plasma amine oxidase by haloallylamines", Bioorganic & Medicinal Chemistry2006, 14(5), 1444.
 6.  J. Kim; S‑B. Park; N. Y. Tretyakova; C. R. Wagner "A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry", Molecular Pharmaceutics, 2005, 2, 233.
 5.  J. Kim; T‑f. Chou; G. W. Griesgraber; C. R. Wagner "Direct measurement of nucleoside monophosphate delivery from a phosphoramidate pronucleotide by stable isotope labeling and LC-ESI-MS/MS", Molecular Pharmaceutics, 2004, 1, 102.
 4.  J. Kim; D. P. Drontle; C. R. Wagner "Monitoring the intracellular metabolism of nucleoside phosphoramidate pronucleotides by 31P NMR", Nucleosid. Nucleotid. Nucl. Acids, 2004, 23 (1), 483.
 3.  J. Kim; C. R. Wagner "Studies of the intracellular metabolism of nucleoside amino acid phosphoramidates utilizing 31P NMR and LC/MS", Antiviral Res., 2003, 57, 47.
 2.   C. K. Koh Choo; K. H Kim; Y. E Lee; J. S. Kim "A scientific study of Choson white ware: early porcelain from a royal kiln at Kwangju Usanni", Archaeometry, 2002 (May), 44(2), 199.
 1.  K. Ling.; J. Kim; L. M. Sayre "Catalytic turnover of benzylamine by a model for the lysine tyrosylquinone (LTQ) cofactor of lysyl oxidase", J. Am. Chem. Soc., 2001, 123, 9606.
©